# Expression Analysis of Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation of Its Clinical Diagnostic Value

> **NCT06123871** · — · UNKNOWN · sponsor: **Yipeng Liu** · enrollment: 30 (estimated)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **OTHER:** Grouping based on previous laboratory results, no intervention.

## Key facts

- **NCT ID:** NCT06123871
- **Lead sponsor:** Yipeng Liu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-01-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06123871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06123871, "Expression Analysis of Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation of Its Clinical Diagnostic Value". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06123871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*